Analyst
Corporate Communications
Head of Investor Relations
Rhythm Pharmaceuticals, Inc. (RYTM)Equibles does not estimate personal net worth.
David Connolly is recorded as Analyst at Corporate Communications and Head of Investor Relations at Rhythm Pharmaceuticals, Inc. (RYTM). David Connolly has spoken on 17 earnings calls across 1 company, most recently for Rhythm Pharmaceuticals, Inc. on November 3, 2026. Rhythm Pharmaceuticals, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Rhythm Pharmaceuticals, Inc. includes David P. Meeker, M.D. (CEO and Chairman), Hunter Smith (CEO and CFO), David Meeker (Chairman) and 6 others.
“For those of you participating on the conference call, our slides can be accessed and controlled by going to the Investor section of our website, ir.rhythmtx.com. Last night, we issued a press release announcing the amendment to our BIVA-Mellagon licensing agreement, and this morning, we issued our press release that…”
“For those of you participating on the conference call, our slides can be accessed and controlled by going to the Investor section of our website, ir.rhythmtx.com. This morning, we issued a press release that provides our Q2 2026 financial results and a business update, and that press release is available on our…”
“Are these mostly in centers of excellence, or are these more one-off? Thanks.”
“For those of you participating on the conference call, our slides can be accessed and controlled by going to the Investor section of our website, ir.rhythmtx.com. This morning, we issued a press release that provides the fourth quarter 2025 and full year 2025 financial results and a business update, and that press…”
“For those of you participating on the conference call, our slides can be accessed and controlled by going to the Investors section of our website, ir.rhythmtx.com. This morning, we issued a press release that provides our Q3 financial results and a business update, and that press release is also available on our…”
Corporate Communications
Analyst
Source not stated
Biotechnology · Healthcare
Head of Investor Relations
